Pharmafile Logo

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

December 1, 2025 |  

- PMLiVE

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.

Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come. 

Among the proven benefits of Medscape AI:

  • Reliability: Clinically Vetted Sources, Transparent By Design
    • Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
    • AI responses are traceable, transparent, and supported by citations 
  • Recency: Always Current and Continuously Updated
    • Integrates verified real-time news, research updates, and guideline changes
    • Daily and weekly editorial oversight ensures outputs reflect the latest evidence 
  • Relevance: Aligned to Practice and Patient Care
    • Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
    • Synthesized insights tuned to each specialty, workflow, and clinical context
    • Guidance supports differential diagnosis, treatment decisions, and next-step care
    • Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools  
  • Time-Saving Clinical Efficiency
    • Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature

“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”

Medscape  is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month. 

 Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!

Educational Symposia

Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.

  • Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
    • Time: 11:30 AM – 1:00 PM ET
    •  Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK
  • Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
    • Time: 11:30 AM – 1:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International DEFG 
  • Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
    • Time: 11:30 AM – 1:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
    • Time: 3:30 PM – 5:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
    • Time: 3:30 PM – 5:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK

ASH Abstract Publication 

Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood

For more information, please contact Jelena Spyropoulos.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

More Than Pink Walls: What Women-Centric Care Actually Requires

The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear…

Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.

Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…

Moving Beyond the 10%: A New Era in Preterm Birth Prevention

For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause…

Medscape Education to Showcase the Impact of Neurology CME at EAN 2026

Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,…

Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education

Medscape Education has been recognized with 2 prestigious accolades at the Spring 2026 Digital Health Awards. The premier digital education platform earned a Gold Award for its PIONEER initiative in…

Medscape Education Brings AI to the Hematology Frontline at EHA 2026

Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress in Stockholm on June 11, 2026.

The Ripple Effect: Why Connection is the Heart of Healthcare Leadership

In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin Nwafor (Gilead Sciences) and Dr. Shirin Mazumder (University of…

Beyond the Nudge: Why Mentorship is the New Healthcare Currency

In the latest episode of Hear From Her, the conversation centers on a striking reality: women in healthcare often face a “confidence gap” that their male counterparts do not. While…

Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026

Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.

How Sweet It Is: Medscape at ADA 2026

The energy is building as we prepare to head to New Orleans, LA, for the annual scientific sessions of the American Diabetes Association from June 4-8. The Medscape Diabetes and…